Skip to content
RDL Network logo
TCT-415 Absorb Bioresorbable Vascular Scaffolds vs. XIENCE Everolimus-Eluting Stents: Are Clinical Outcomes Different for Men and Women? — Dean J. Kereiakes (2016) | RDL Network